Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA DR. REDDYS LAB CIPLA/
DR. REDDYS LAB
 
P/E (TTM) x 32.4 24.6 131.9% View Chart
P/BV x 4.0 3.8 105.5% View Chart
Dividend Yield % 0.5 0.7 70.2%  

Financials

 CIPLA   DR. REDDYS LAB
EQUITY SHARE DATA
    CIPLA
Mar-22
DR. REDDYS LAB
Mar-22
CIPLA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0835,614 19.3%   
Low Rs8063,655 22.1%   
Sales per share (Unadj.) Rs269.71,294.6 20.8%  
Earnings per share (Unadj.) Rs31.7126.9 25.0%  
Cash flow per share (Unadj.) Rs44.8196.9 22.7%  
Dividends per share (Unadj.) Rs5.0030.00 16.7%  
Avg Dividend yield %0.50.6 81.8%  
Book value per share (Unadj.) Rs257.81,145.8 22.5%  
Shares outstanding (eoy) m806.81166.43 484.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.6 97.8%   
Avg P/E ratio x29.836.5 81.6%  
P/CF ratio (eoy) x21.123.5 89.7%  
Price / Book Value ratio x3.74.0 90.6%  
Dividend payout %15.823.6 66.7%   
Avg Mkt Cap Rs m762,177771,272 98.8%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29938,858 90.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633215,452 101.0%  
Other income Rs m3,2174,847 66.4%   
Total revenues Rs m220,851220,299 100.3%   
Gross profit Rs m43,29837,674 114.9%  
Depreciation Rs m10,52011,652 90.3%   
Interest Rs m1,064958 111.0%   
Profit before tax Rs m34,93329,911 116.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3388,789 106.2%   
Profit after tax Rs m25,59521,122 121.2%  
Gross profit margin %19.917.5 113.8%  
Effective tax rate %26.729.4 91.0%   
Net profit margin %11.89.8 120.0%  
BALANCE SHEET DATA
Current assets Rs m147,108177,880 82.7%   
Current liabilities Rs m49,12997,658 50.3%   
Net working cap to sales %45.037.2 120.9%  
Current ratio x3.01.8 164.4%  
Inventory Days Days6356 112.8%  
Debtors Days Days6113 5.1%  
Net fixed assets Rs m119,415106,819 111.8%   
Share capital Rs m1,614832 193.9%   
"Free" reserves Rs m206,364189,859 108.7%   
Net worth Rs m207,977190,691 109.1%   
Long term debt Rs m4,1625,746 72.4%   
Total assets Rs m266,523284,699 93.6%  
Interest coverage x33.832.2 105.0%   
Debt to equity ratio x00 66.4%  
Sales to assets ratio x0.80.8 107.9%   
Return on assets %10.07.8 129.0%  
Return on equity %12.311.1 111.1%  
Return on capital %17.015.7 108.0%  
Exports to sales %26.247.1 55.7%   
Imports to sales %8.218.8 43.6%   
Exports (fob) Rs m57,094101,544 56.2%   
Imports (cif) Rs m17,80340,401 44.1%   
Fx inflow Rs m60,180101,544 59.3%   
Fx outflow Rs m17,80340,401 44.1%   
Net fx Rs m42,37661,143 69.3%   
CASH FLOW
From Operations Rs m33,25928,108 118.3%  
From Investments Rs m-18,719-26,387 70.9%  
From Financial Activity Rs m-15,998-2,422 660.5%  
Net Cashflow Rs m-1,32332 -4,135.0%  

Share Holding

Indian Promoters % 13.5 26.7 50.5%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.0 51.1 95.9%  
FIIs % 27.6 25.9 106.8%  
ADR/GDR % 0.0 10.4 -  
Free float % 66.4 62.9 105.5%  
Shareholders   418,910 255,300 164.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    LUPIN    PIRAMAL ENTERPRISES    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 418 Points, Nifty Ends Above 17,900; Bajaj Twins and Bharti Airtel Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains as the session progressed and ended near day's high.